Asian Tribune Your Multilingual Newspaper covering World and local news News
Indian drug manufacturers who have signed up with Russia’s RDIF to produce Sputnik V are struggling to scale up production of the second component of the Covid-19 vaccine, and are now counting on the approval for the single-shot Sputnik Light to salvage the situation, reports Viswanath Pilla. A top executive …
Read More »Sputnik: Local drug companies find it hard to produce Sputnik’s second component
